Bonesupport Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
174
- Stock Symbol
-
BONEX
- Investments
-
2
- Share Price
-
$32.00
- (As of Friday Closing)
Bonesupport General Information
Description
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
Contact Information
Website
www.bonesupport.comCorporate Office
- Scheelevagen 19
- 223 70 Lund
- Sweden
Corporate Office
- Scheelevagen 19
- 223 70 Lund
- Sweden
Bonesupport Stock Performance
As of 13-Nov-2026, Bonesupport’s stock price is $32.00. Its current market cap is $2.08B with 65.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $32.00 | $31.78 | $17.90 - $34.27 | $2.08B | 65.1M | 365K | $0.44 |
Bonesupport Financials Summary
As of 30-Sep-2026, Bonesupport has a trailing 12-month revenue of $149M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,443,315 | 1,307,853 | 2,301,967 | 1,209,976 |
| Revenue | 149,113 | 119,562 | 84,978 | 55,609 |
| EBITDA | 39,979 | 21,031 | 17,157 | 2,258 |
| Net Income | 28,922 | 14,469 | 12,647 | 23,052 |
| Total Assets | 116,929 | 112,600 | 79,729 | 68,923 |
| Total Debt | 1,063 | 1,270 | 1,322 | 1,749 |
Bonesupport Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bonesupport Comparisons
Industry
Financing
Details
Bonesupport Competitors (1)
One of Bonesupport’s competitors is OssDsign, a Formerly VC-backed company based in Uppsala, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| OssDsign | Formerly VC-backed | Uppsala, Sweden |
Bonesupport Patents
Bonesupport Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2987390-T3 | Novel combination treatment regimen for bacterial infections | Active | 04-Mar-2022 | ||
| AU-2023228062-A1 | Novel combination treatment regimen of bacterial infections | Pending | 04-Mar-2022 | ||
| EP-4291200-A1 | Novel combination treatment regimen of bacterial infections | Active | 04-Mar-2022 | ||
| EP-4291200-B1 | Novel combination treatment regimen of bacterial infections | Active | 04-Mar-2022 | ||
| EP-4291200-C0 | Novel combination treatment regimen of bacterial infections | Active | 04-Mar-2022 | A61K38/14 |
Bonesupport Signals
Bonesupport Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bonesupport Investments & Acquisitions (2)
Bonesupport’s most recent deal was a Merger/Acquisition with Ultrazonix DNT. The deal was made on 27-Oct-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ultrazonix DNT | 27-Oct-2008 | Merger/Acquisition | Diagnostic Equipment | ||
| Seagles (Gelatin/CERAMENT biomaterial IP in Lund, Sweden) | Corporate Asset Purchase | Buildings and Property |
Bonesupport ESG
Risk Overview
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Bonesupport Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Seagles (Gelatin/CERAMENT biomaterial IP in Lund, Sweden) | Lund, Sweden | 2010 |
Bonesupport FAQs
-
When was Bonesupport founded?
Bonesupport was founded in 2000.
-
Where is Bonesupport headquartered?
Bonesupport is headquartered in Lund, Sweden.
-
What is the size of Bonesupport?
Bonesupport has 174 total employees.
-
What industry is Bonesupport in?
Bonesupport’s primary industry is Pharmaceuticals.
-
Is Bonesupport a private or public company?
Bonesupport is a Public company.
-
What is Bonesupport’s stock symbol?
The ticker symbol for Bonesupport is BONEX.
-
What is the current stock price of Bonesupport?
As of 13-Nov-2026 the stock price of Bonesupport is $32.00.
-
What is the current market cap of Bonesupport?
The current market capitalization of Bonesupport is $2.08B.
-
What is Bonesupport’s current revenue?
The trailing twelve month revenue for Bonesupport is $149M.
-
Who are Bonesupport’s competitors?
OssDsign is a competitor of Bonesupport.
-
What is Bonesupport’s annual earnings per share (EPS)?
Bonesupport’s EPS for 12 months was $0.44.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process